Chemed Corporation
Every calculator, already run for CHE
Open the full toolkit →You have the numbers on CHE. Get the argument.
A written report on which of these readings actually decide the outcome for Chemed Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
4 analysts covering CHEAnalyst Price Target Disagreement for Chemed Corporation
Wall Street's bull case implies +14% from the current price; the bear case implies +0%. Analysts are relatively aligned on CHE's range.
Ownership & short interest
Insider Trading Activity for CHE
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporate…
CHE — frequently asked
Is CHE a buy right now?
Wall Street's consensus rating on Chemed Corporation is none across 4 analysts, with a mean price target of $552.00 (+6% vs. the current $519.01). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CHE overvalued?
CHE trades at 26.1x trailing earnings, against a DCF fair value of $757 per share. The current price implies 1% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CHE's next earnings date?
Chemed Corporation is next scheduled to report earnings around Oct 27, 2026. A full CHE research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Chemed Corporation?
Analysts covering Chemed Corporation (CHE) range from a bear-case target of $520.00 to a bull-case high of $590.00, with a mean consensus target of $552.00 across 4 analysts. The spread of $70.00 (13% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Chemed Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Chemed Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CHE research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Chemed Corporation, in minutes. 3 free reports included with every account — no credit card required.